Volcano Corporation Commends the Elevation of FFR to Level of Evidence A in New PCI Guidelines
Volcano Corporation , a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, reacted positively to the new guidelines for treating coronary disease and heart attacks using percutaneous coronary intervention , a procedure that treats narrowed blood vessels.
Read Full Article
Login to comment.